Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1132765

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	1
legislature	25259 pref label House of Commons
question text	What recent discussions his Department has had with clinical commissioning groups on the Human Fertilisation and Embryology Authority’s guidance on fertility treatment.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	911423
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>Clinical commissioning groups (CCGs) have a statutory responsibility to commission healthcare services that meet the needs of their whole population, including fertility services. The Human Fertilisation and Embryology Aauthority’s guidance for commissioners is a new tool to help them implement National Institute for Health and Care Excellence (NICE) Fertility guidelines and utilise the benchmark price for In Vitro Fertilisation.</p><p>I have written to all CCGs to promote the guidance and benchmark price, and encourage them to fully implement NICE Fertility Guideline recommendations.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/06/2019 15:21:37 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	298 label Biography information for Steve McCabe

1132760

registered interest
date	18/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Mental Health
house id	1
legislature	25259 pref label House of Commons
question text	What steps he is taking to help protect the mental health of NHS staff.
tabling member constituency	Thornbury and Yate
tabling member printed	Luke Hall
uin	911417
answer	answer is ministerial correction date of answer 18/06/2019 answer text <p>The NHS People Plan will develop a new offer for our people through which they will have voice and support including a focus on improved mental health.</p><p>This will build on progress implementing mental health standards in ‘Thriving at Work – a review of mental health and employers’, which have been included in NHS Standard Contracts and embedded in the National Health Service staff health and wellbeing framework.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 18/06/2019 14:50:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4450 label Biography information for Luke Hall

1105058

registered interest
date	26/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Staff
house id	1
legislature	25259 pref label House of Commons
question text	What steps he is taking to help protect the mental health of NHS staff.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	910041
answer	answer is ministerial correction date of answer 26/03/2019 answer text <p>Protecting the mental health of our hard-working National Health Service staff is very important. That’s why the Workforce Implementation Plan, led by Baroness Harding, will outline proposals for making the NHS ‘the best place to work’. Through this, we will be supporting employers who are responsible for staff mental health by investing in an expanded programme to implement the NHS staff health and wellbeing framework launched last year.</p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 26/03/2019 16:31:28 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1566 label Biography information for Daniel Kawczynski

1063847

registered interest
date	19/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Self-harm and Suicide: Children
house id	1
legislature	25259 pref label House of Commons
question text	What steps he is taking to prevent self-harm and suicide among children.
tabling member constituency	East Renfrewshire
tabling member printed	Paul Masterton
uin	909318
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>Although suicides among children are relatively rare, I am concerned about increases in suicide and self-harm amongst teenagers. As Suicide Prevention Minister I am personally committed to do whatever we can to prevent suicides in children.</p><p>We have challenged social media companies to step up and protect children from harmful suicidal and self-harm content and cyberbullying.</p><p>The NHS long-term plan commits to increasing funding for children and young people’s mental health services which will ensure children can access the right support, including crisis care provision.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 19/02/2019 16:51:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4625 label Biography information for Paul Masterton

1063846

registered interest
date	19/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Alcoholic Drinks
house id	1
legislature	25259 pref label House of Commons
question text	What discussions he has had with the Home Secretary on including awareness-raising of the risks of pre-natal exposure to alcohol in the Government's alcohol strategy.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	909317
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>Through the NHS Maternity Transformation Programme, Public Health England is leading work to raise awareness of the risks of pre-natal exposure to alcohol. A reduction in the proportion of women drinking alcohol during pregnancy has been identified as a public health priority for the five-year programme.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 19/02/2019 16:51:04 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4061 label Biography information for Bill Esterson

1141381

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	MMR Vaccine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	280999
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Two Measles, Mumps and Rubella (MMR) vaccines are licensed for use in the United Kingdom: M-M-RVaxPro and Priorix. Both vaccines are on the National Health Service’s routine immunisation schedule. The quality, safety and efficacy of both M-M-RVaxPro and Priorix have been evaluated before they were given a Marketing Authorisation in Europe, and the Marketing Authorisation Holder for each vaccines is legally required to submit periodic safety update reports to the regulator, which are documents intended to provide an evaluation of the risk-benefit balance of a medicinal product at defined time points after its authorisation. The sites at which the products are manufactured are also required to undergo periodic inspections to ensure that they comply with Good Manufacturing Practices. Each batch of vaccines is tested by an official medicines control laboratory (OMCL). OMCL testing is independent of and in addition to the manufacturer’s testing. These procedures ensure that the MMR vaccines available in the UK are safe and efficacious and that the manufacturers/Marketing Authorisation holders are held accountable for their products.</p><p>A European Public Assessment Report (EPAR) for M-M-RVaxPro is available at the following link:</p><p><a href="https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf" target="_blank">https://www.ema.europa.eu/en/documents/scientific-discussion/m-m-rvaxpro-epar-scientific-discussion_en.pdf</a></p><p>Priorix was approved before public assessment reports were a requirement. The EPAR for M-M-RVaxPro contains a general summary of the manufacturing information that was provided during the assessment process; however, the specific details of the manufacturing process are confidential.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:38:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1522 label Biography information for Adam Holloway

1141380

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	MMR Vaccine: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to maintain and improve pharmacovigilance in relation to the MMR vaccine.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	280998
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>As with all vaccines and medicines, the safety of the Measles, Mumps and Rubella (MMR) vaccine remains under continual review by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA uses all available sources of evidence in pharmacovigilance, including regular review of suspected adverse reactions submitted through the Yellow Card Scheme, data from clinical and epidemiological studies, the medical literature and information from pharmaceutical companies and other worldwide regulatory authorities. The MHRA’s processes and data analysis systems are regularly evaluated to ensure optimal performance in monitoring the safety of vaccines and medicines.</p><p>The balance of benefits and risks of MMR vaccine remains overwhelmingly favourable.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:35:38 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1522 label Biography information for Adam Holloway

1141255

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Non-surgical Cosmetic Procedures: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what legal duties govern the administering of dermal fillers to people under the age of 18 by non-regulated practitioners.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	280927
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Currently there are no restrictions that limit the administration of dermal fillers on young people under the age of 18 years old.</p><p>The Department is exploring options to introduce age restrictions on access to cosmetic procedures, bringing them in line with legislation on tattoos, teeth whitening and the use of sunbeds. From May 2020 all dermal fillers, irrespective of their composition and intended use, will be regulated as medical devices under Annex XVI of the Medical Device Regulations (EU 2017/745). The new Regulations will significantly improve the quality and safety of dermal fillers.</p><p>The Government is committed to improving the safety of cosmetic procedures through better training for practitioners, and clear information so that people can make informed decisions about their care. The growth in non-surgical treatments increases the need for consumer protection and we are currently working with stakeholders to strengthen the regulation of cosmetic procedures.</p><p>We urge anyone seeking a cosmetic procedure to take the time to find a reputable, insured and appropriately qualified practitioner who is either subject to statutory regulation or on a voluntary register accredited by the Professional Standards Authority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:32:36 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1438 label Biography information for Lord Beamish

1140972

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made of the adequacy of palliative care arrangements and support in place for the victims of the contaminated blood scandal.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	280426
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The England Infected Blood Support Scheme (EIBSS) does not currently have direct support provisions for palliative care arrangements. EIBSS does however support beneficiaries to manage their health conditions via discretionary one-off payments.</p><p>Discretionary one-off payments are a form of financial support that beneficiaries and bereaved spouses/partners may apply for to cover the cost of certain essential, health-related items or services.</p><p>Some examples of the one-off payments we support are for home adaptations and repairs to support an individual’s medical conditions, assisting with respite breaks to aid recovery from periods of ill health and supporting the attendance of appointments by providing payments for car repairs and travel costs.</p><p>A full list of the items or services currently supported through EIBSS is available on the NHS Business Services Authority website at the following link:</p><p><a href="https://www.nhsbsa.nhs.uk/support-scheme-members/discretionary-support-scheme" target="_blank">https://www.nhsbsa.nhs.uk/support-scheme-members/discretionary-support-scheme</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:01:54 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4523 label Biography information for Catherine West

1140913

registered interest
date	22/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternal Mortality
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the MBRRACE-UK maternal deaths and morbidity statistics 2014-16 showing that (a) Asian women are nearly twice as likely, (b) mixed race women are twice as likely and (c) black women are five times as likely to die during or up to six weeks after pregnancy than white women.
tabling member constituency	Newport West
tabling member printed	Ruth Jones
uin	280405
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The NHS Long Term Plan takes a concerted and systematic approach to reducing health inequalities and addressing unwarranted variation in care. NHS England and NHS Improvement are leading the work through the Maternity Transformation Programme to support maternity services to provide high-quality maternity care for all women.</p><p>Targeted and enhanced continuity of carer can significantly improve outcomes for women from ethnic minorities. The NHS Long Term plan sets out that 75% of black women will receive continuity of carer from midwives by 2024.</p><p>The Department is also funding research to investigate the factors associated with the excess perinatal mortality experienced by black/black British and Asian/Asian British ethnic groups and identify the factors associated with the excess risk of maternal death for black and South Asian women.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:19:04 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4716 label Biography information for Ruth Jones